Corticosteroids usage in pediatric liver transplantation: To be or not to be!

Pediatric Transplantation

Volumn 13, Issue 2, 2009, Pages 160-170

  Al Sinani, Siham ^a   Dhawan, Anil ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Corticosteroids; de novo autoimmune hepatitis; Growth post liver transplantation; Immunosuppression; Liver transplantation

Indexed keywords

BASILIXIMAB; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; OKT 3; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

AUTOIMMUNE HEPATITIS; CLINICAL TRIAL; DRUG WITHDRAWAL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; REVIEW; RISK BENEFIT ANALYSIS; SURVIVAL RATE;

ADRENAL CORTEX HORMONES; CHILD; GRAFT REJECTION; GRAFT SURVIVAL; GROWTH; GROWTH DISORDERS; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; STEROIDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 59449085689     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.01043.x     Document Type: Review

References (45)

1. Dhawan A, Seemayer TA, Pinsinski C, Gross TG, Shaw BW, Mack DR. Post transplant eosinophilic gastroenteritis in children. Liver Transplant Surg 1997 : 3 : 591 593.
2. Al-Hussaini A, Tredger M, Dhawan A. Immunosuppression in pediatric liver and intestinal transplantation: A closer look at the arsenal. JPGN 2005 : 41 : 152 165.
3. Berki T, Tavakoli A, Nagy KK, Nagy G, Nemeth P. Alterations of glucocorticoid receptor expression during glucocorticoid hormone therapy in renal transplant patients. Transpl Int 2002 : 15 : 132 138.
4. Goodwin WE, Kaufman J, Mims MM, et al. Human renal transplantation. Clinical experience with six cases of renal transplantation. J Urol 1963 : 89 : 13 24.
5. Starlz TE, Marchioro TL, Waddle WR. The reversal of rejection in human renal homografts with subsequent development of homograft tolerance. Surg Gynecol Obstet 1963 : 117 : 385 395.
6. Fine RN, Otte JB, Tejani A. Corticosteroid elimination in pediatric solid organ transplantation. Pediatr Transplant 1998 : 2 : 3 5.
7. Superina RA, Zangari A, Acal L, Deluca E, Zaki A, Kimmel S. Growth in children following liver transplantation. Pediatr Transplant 1998 : 2 : 70 75. (Abstract).
8. Asonuma K, Inomata Y, Uemoto S, et al. Growth and quality of life after living-related liver transplantation in children. Pediatr Transplant 1998 : 2 : 64 69.
9. Abe M, Fuchinoue S, Koike T, et al. Successful prednisone withdrawal after living-related liver transplantation. Transplant Proc 1998 : 30 : 1441 1442.
10. Toyoki Y, Hakamada K, Narumi S, et al. Primary immunosuppression regimen of rapid steroid withdrawal after living related liver transplantation: A single-center experience. Transplant Proc 2004 : 36 : 2279 2281.
11. Sindhi R, Ganjoo J, McGhee W, Mazariegos G, Reyes J. Preliminary immunosuppression withdrawal strategies with sirolimus in children with liver transplants. Transplant Proc 2002 : 34 : 1972 1973.
12. Mazariegos GV, Sindhi R, Smith A, McGhee W, Fung JJ, Reyes J. Rabbit anti-thymocyte globulin (rATG) induction therapy for pediatric steroid free liver transplantation. Pediatr Transplant 2003 : 7 (Suppl. 4 20 30.
13. Reding R, Gras J, Sokal E, Otte JB, Davies Hugh FS. Steroid-free liver transplantation in children. Lancet 2003 : 362 : 9401.
14. Spada M, Petz W, Bertani A, et al. Randomized trail of basiliximab induction versus steroid therapy in pediatric liver allograft recipients under tacrolimus immunosuppression. Am J Transplant 2006 : 6 : 913 921.
15. Cintorino D, Riva S, Spada M, et al. Corticosteroids-free immunosuppression in pediatric liver transplantation: Safety and efficacy after a short-term follow-up. Transplant Proc 2006 : 38 : 1099 1100.
16. Kato T, Selvaggi G, Panagiotis T, et al. Pediatric liver transplant with Campath 1H induction-preliminary report. Transplant Proc 2006 : 38 : 3609 3611.
17. Gras J, Gerkens S, Beguin C, et al. Steroid-free, tacrolimus-basiliximab immunosuppression in pediatric liver transplantation: Clinical and pharmacoeconomic study in 50 children. Liver Transplant 2008 : 14 : 469 477.
18. Urbach AH, Gartner JC, Malatack JJ, et al. Linear growth following pediatric liver transplantation. Am J Dis Child 1987 : 141 : 547 549.
19. Busuttil RW, Colonna JO, Hiatt JR, et al. The first 100 liver transplants at UCLA. Ann Surg 1987 : 206 : 4.
20. Spolidoro JV, Berquist WE, Pehlivanoglu E, et al. Growth acceleration in children after orthotopic liver transplantation. J Pediatr 1988 : 112 : 41 44.
21. Stewart SM, Uauy R, waller DA, Kennard BD, Benser M, Andrews WS. Mental and motor development, social competence and growth one year after successful pediatric liver transplantation. J Pediatr 1989 : 114 : 574 581.
22. Chin SE, Shepherd RW, Cleghorn G, et al. Survival, growth and quality of life in children after orthotopic liver transplantation: A 5 year experience. J Paediatr Child Health 1991 : 27 : 380 385.
23. Dunn SP, Falkenstein K, Lawrence JP, et al. Monotherapy with cyclosporine for chronic immunosuppression in pediatric liver transplant recipients. Transplantation 1994 : 57 : 4.
24. Codoner-Franch P, Bernard O, Alvarez F. Long-term follow-up of growth in height after successful liver transplantation. J Pediatr 1994 : 124 : 368 373.
25. McDiarmid SV, Farmer DA, Goldstein LI, et al. A randomized prospective trial of steroid withdrawal after liver transplantation. Transplantation 1995 : 60 : 1443 1450.
26. Holt RI, Broide E, Buchanan CR, et al. Orthotopic liver transplantation reverses the adverse nutritional changes of end-stage liver disease in children. Am J Clin Nutr 1997 : 65 : 534 542.
27. Bartosh SM, Thomas SE, Sutton MM, Brady LM, Whitington PF. Linear growth after pediatric liver transplantation. J Pediatr 1999 : 135 : 624 631.
28. Viner RM, Forton JTM, Cole TJ, Clark IH, Nobel-Jasmieson GN, Barnes ND. Growth of long term survivors of liver transplantation. Arch Dis Child 1999 : 80 : 235 240.
29. McDiarmid SV, Gornbein JA, DeSilva PJ, et al. Factors affecting growth after pediatric liver transplantation. Transplantation 1999 : 67 : 404 411.
30. Renz JF, de Roos M, Rosenthal P, et al. Posttransplantation growth in pediatric liver recipients. Liver Transplant 2001 : 7 : 1040 1055.
31. Reding R. Steroid withdrawal in liver transplantation: Benefits, risks, and unanswered questions. Transplantation 2000 : 70 : 405 410.
32. Vo Thi Diem H, Sokal EM, Janssen M, Otte JB, Reding R. Steroid withdrawal after pediatric liver transplantation: A long-term follow-up study in 109 recipients. Transplantation 2003 : 75 : 1664 1670.
33. Lopez-Espinosa JA, Yeste-Fernandez D, Iglesias-Berengue J, et al. Factors affecting catch-up growth after liver transplantation. J Pediatr Endocrinol Metab 2004 : 17 : 1097 1103.
34. Park SJ, Rim SH, Kim KM, et al. Long-term growth of pediatric patients following living-donor liver transplantation. J Korean Med Sci 2005 : 20 : 835 840.
35. Kerkar N, Hadzic N, Davies ET, et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998 : 351 : 409 413.
36. Hernandez H, Kovarik P, Whitington P, et al. Autoimmune hepatitis as a late complication of liver transplantation. JPGN 2001 : 32 : 131 136.
37. Salcedo M, Vaquero J, Banares R, et al. Serum autoantibodies after liver transplantation. Prevalence and associated immunologic disorders. J Hepatol 2001 : 34 (Suppl. 1 47. (Abstract).
38. Gupta P, Hart J, Millis JM, Cronin D, Brady L. De novo hepatitis with auto immune antibodies and atypical histology. Transplantation 2001 : 71 : 664 668.
39. Andries S, Casamayou L, Sempoux C, et al. Posttransplant immune hepatitis in pediatric liver transplant recipients: Incidence and maintenance therapy with azathioprine. Transplantation 2001 : 72 : 267 272.
40. Vergani D, Mieli-Vergani G. Autoimmunity after liver transplantation. Hepatology 2002 : 36 : 271 276.
41. Venick RS, McDiarmid SV, Farmer DG, et al. Rejection and steroid dependence: Unique risk factors in the development of pediatric posttransplant De novo autoimmune hepatitis. Am J Transplant 2007 : 7 : 955 963.
42. Bogdanos DP, Choudhri K, Vergani D. Molecular mimicry and autoimmune liver disease: Virtuous intentions, malign concerns. Liver 2001 : 21 : 225 232.
43. Gao E, Lo D, Cheney R, Kanagawa O, Sprent J. Abnormal differentiation of thymocytes in mice treated with cyclosporine A. Nature 1988 : 336 : 176 179.
44. Bucy PB, Yan Xu X, Li J, Huang GQ. Cyclosporin A-induced autoimmune disease in mice. J Immunol 1993 : 151 : 1039 1050.
45. Salcedo M, Vaquero J, Banares R, et al. Response to steroids in de novo autoimmune hepatitis after liver transplantation. Hepatology 2002 : 35 : 349 356.